Press Releases :: Ligand Pharmaceuticals Incorporated (LGND)

Press Releases

Ligand Reports Fourth Quarter and Full Year 2014 Financial Results

February 9, 2015

Ligand Partner GlaxoSmithKline Announces EU Regulatory Submission Seeking Additional Indication for Revolade®

February 6, 2015

Ligand Signs License Agreement with Sermonix for Lasofoxifene

February 3, 2015

Ligand Promotes Matthew W. Foehr to President

February 2, 2015

Ligand to Present at BIO CEO and RBC Capital Markets Global Healthcare Conferences in February

January 28, 2015

Ligand to Report Fourth Quarter Results on February 9th

January 27, 2015

Ligand Partner Retrophin Receives Orphan Drug Designation for Sparsentan

January 9, 2015

Ligand Partner Melinta Therapeutics Reports Positive Phase 3 Results for Captisol-enabled™ Delafloxacin IV

January 8, 2015